Bio-Path Holdings Announces Publication in The Lancet Haematology

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018

Bio-Path Holdings to Present Data at the 2018 AACR Annual Meeting

BP1001 phase I-Ib protocol

View document

Bio-Path Holdings to Present at the 30th Annual ROTH Conference

Drug Development and Delivery Published Article: DNA THERAPEUTICS – DNAbilize-ING Antisense

Published Article

Bio-Path Holdings Announces 1-for-10 Reverse Stock Split

BPTH – Certificate of Amendment to Certificate of Incorporation (2-7-18)

BPTH – Certificate of Amendment to Certificate of Incorporation (2-7-18)

BPTH – Certificate of Amendment to Certificate of Incorporation (2-7-18)

BPTH – Certificate of Amendment to Certificate of Incorporation (2-7-18)

BPTH – Certificate of Amendment to Certificate of Incorporation (2-7-18)

BPTH – Certificate of Amendment to Certificate of Incorporation (2-27-24)